| 1 |
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?
|
3. They enhance sensitivity and surface area for detection |
|
Nanomaterials give multiple benefits towards medical diagnostics, mainly for better sensitivity and surface area for detection as they are smaller in size, increasing the surface area for detecting biomarkers, giving better quality detection.
|
Supporting this reason, the nanomaterials are in nanoscale, they improve chemical reactivity which leads to better performance of diagnostic sensor and detection.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?
|
2. Gold nanoparticles |
|
gold nanoparticles are beneficial in increasing conductivity because of it's material allowing more electron transfer.
|
"Nanomaterials exhibit excellent electrical conductivity, which enhances electron transfer between the electrode and the target biomolecules. " which is why gold nanoparticles are modified into glucose sensors, so that there is more sensitivity in detection.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?
|
3. They improve electron transfer and mechanical strength |
|
Carbon nanotubes are effective due to their large surface area, including their electrical properties
|
table 3. Carbon Nanotubes (CNTs) High surface area and excellent electrical properties improve signal transduction Can be functionalized with various biological molecules for selective detection
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?
|
3. Issues in reproducibility and standardization |
|
Nanotechnology still has it's limitations in reproducibility because of it's small scale, issues may occur more easily. For instance, small changes in size, shape, and surface properties can have a large effect towards the electochemical behavior. Most nanomaterials are sensitive towards degrading because of harsh environments. It's small properties can also lead to noise. Fabrication of nanomaterials can lead to little robust results, having little reliability.
|
"Inconsistent sensor responses. Minor variations in size, shape, and surface properties of nanomaterials can significantly impact their electrochemical behavior. Many nanomaterials, such as metal nanoparticles, are prone to oxidation and agglomeration, which can degrade their performance over time. "(7.11) All these issues could be reasons to why there has been inconsistent results.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?
|
3. Antibody fragmentation |
|
This technique is commonly used because of it's accuracy, it detects biomarkers by putting in the specific antibody. For instance, it'll specifically, fragmentize in a pathogen, only detecting that pathogen to infuse the lock and key method.
|
It gives specific and accurate results, which are clear and concise. "fabrication of microelectrode arrays with precisely defined geometries, enhancing the sensor's sensitivity and enabling multiplexed detection of multiple analytes"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?
|
2. To prevent rejection or toxicity in biological systems |
|
Because nanomaterials may have immune reaction or cytotoxicity towards the sensors which will limit the sensor's use as it will wear the sensors down. Eventually, the sensors will have little effect, making them less reliable in detection.
|
"Ensuring the biocompatibility of nanomaterials is crucial for in vivo applications. Some nanomaterials may induce cytotoxicity or immune responses, limiting their clinical utility [74]." (4.3.1)
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How do label-free electrochemical sensors differ from labeled ones?
|
4. They need longer sample preparation time |
|
Label sensors are faster and more effective, because they require less sample preparation time.
|
It requires less time as they are more developed.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one promising application of nanotech-based electrochemical sensors?
|
2. Early detection of disease biomarkers |
|
Because of it's sensitivity and specificity, nanotechnology allows for early disease detection. It's small scale and high surface area makes great use for detecting small biomarkers that may evolve into diseases.
|
"For instance, gold nanoparticles can enhance the electrochemical signal by providing a large surface area for the immobilization of biomolecules, leading to higher sensitivity in detecting low-abundance biomarkers" (1.3.1) Due to it's small scale there are multiple benefits that comes with it.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which of the following factors most directly affects the sensor's detection limit?
|
2. Nanomaterial surface-to-volume ratio |
|
having more surface to volume ratio provides more active sites for target biomolecules, this affects detection limits. If there are little surface to volume ratio there will be less active sites for biomolecules to react to, higher detection limits, and vise versa.
|
The integration of nanomaterials into electrochemical sensors has markedly improved their sensitivity and specificity. Nanoparticles, nanowires, nanotubes, and other nanostructures provide a high surface area-to-volume ratio, which increases the number of active sites available for interaction with target biomolecules. This results in lower detection limits,
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is one of the primary goals of using digital sensing technologies in cancer care?
|
3. Enable earlier and more personalized diagnosis |
|
As nanotechonogy becomes more advanced, detecting single molecules, it allows for more personalized care for cancer patients. Nanomaterials have more sensitivity, specificity, and fast response time this can be used to detect small cancer biomarkers to improve treatment.
|
As nanotechnology can now detect single molecules and complex biological samples, it can "provide detailed insights into" diseases such as cancer, giving a faster, more personalized way to treat people.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which type of sensor is often used to monitor physical activity in cancer patients?
|
1. Optical sensors |
|
Accelerometers are most commonly use, they have high sensitivity and capture specific cancer biomarkers, give early detection and are non-invasive compared to other methods.
|
" optical biosensors owing to their widespread applications and clinical relevance in cancer detection"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why are patient-reported outcomes important in digital cancer care systems?
|
1. They eliminate clinical trial needs |
|
As these reports are seen as real testing, it eliminates the need for clinical testing as there have already been results.
|
Patient-reported outcomes are the results, this eliminates the need for clinical trial as these reports can be considered a part of the experiment.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is one major advantage of real-time digital sensing in cancer treatment?
|
3. Rapid detection of deterioration in patient condition |
|
Being able to sense cancer biomarkers in real time in fast and accurate rates would be beneficial so that treatment can be given as soon as possible.
|
Nanotechnology-enhanced electrochemical sensors offer a promising alternative for the rapid and sensitive detection of cancer biomarkers (5.1.3) this is crucial as cancer could spread easily and is a deathly condition, if there is fast and accurate detection, there may be less terminal cancer in the future.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?
|
3. Limited digital literacy among patients and providers |
|
As nanotechonology may not have accurate, reliable, robust results yet, it is difficult to build trust among customers and patients, this limits the use and growth of nanotechnology and is a key barrier.
|
"Ensuring the safety, efficacy, and reliability of these advanced sensors is paramount to gaining regulatory approval and public trust." (7.2) public trust and safety is significantly important.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which stakeholders are considered central to the adoption of digital cancer care platforms?
|
2. Patients and healthcare providers |
|
Patients and healthcare providers are the main stakeholders as they are the individuals that are using these products.
|
This product needs to gain approval and public trust to be able to have trials and growth.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Digital sensing systems collect which combination of data types for cancer care optimization?
|
2. Sensor metrics and patient-reported outcomes |
|
these two method combined gives improved patient outcome, supplying accurate and non-invasive results for both real-time and in the future.
|
By combining data from sensor metrics and Patient reports it gives an insight during and after the treatment to be able to improve cancer care.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do digital sensors contribute to improving the quality of life in cancer patients?
|
2. By postponing medical visits indefinitely |
|
digital sensors are a non-invasive way of detection, which can have real time monitoring and decentralized cancer screening using point of care. There would be less hospital visits as patients can now be monitored remotely.
|
"Decentralized cancer screening through point-of-care technologies offers a practical solution for expanding diagnostic services to underserved and remote populations. " when patients can be treated in remote areas, they do not have to visit the hospital often.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What does the article suggest about the future direction of digital sensing in cancer care?
|
4. It depends entirely on manual data input |
|
Manual data input such as AI, multiplexed platforms and different improved technology that allows the future of digital sensing in cancer care to grow.
|
" These upcoming advancements are mainly based on avenues such as multiplexed diagnostic platforms, functionalized nanomaterials, AI and digital medicine expansion, technological biomarker integration, real-time data collection, wearable technologies, and holistic approaches" it will be up to advancement in technology that determinds the future of cancer care.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?
|
4. Analyzing data without measuring electrochemical current |
|
this tool converts chemical reaction into electrical signals, without measuring the electrochemical current the tool would not give out an accurate result.
|
The diagram shows an overview of the electrochemical sensor, it shows how there is biomolecular recognition and how it is converted into a signal output.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?
|
3. A portable chip-based sensor detects protein biomarkers from a blood sample within minutes |
|
allows for non-invasive treatment that doesn't require patients to stay at hospitals for long term and give fast, accurate results.
|
"Tools such as biosensors, electronic noses (e-nose), microfluidic impedance cytometers, and droplet digital PCR (ddPCR) provide early cancer detection by analyzing biological markers with high precision"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|